FEI Reports Record Revenue and EPS for the Fourth Quarter and 2011


Q4 Revenue of $213.0 million, up 14% from Q4-2010

Q4 GAAP Diluted EPS of $0.72, up 38% from Q4-2010

HILLSBORO, Ore., Feb. 8, 2012 (GLOBE NEWSWIRE) -- FEI Company (Nasdaq:FEIC) reported record revenue and earnings for 2011 and for the fourth quarter. Revenue and earnings per share computed on the basis of accounting principles generally accepted in the United States ("GAAP") were the highest of any quarter in the company's history. Several items had an impact on the fourth quarter GAAP results, as detailed below and in the attached table.

Fourth quarter revenue of $213.0 million was up 14% compared to $186.1 million in the fourth quarter of 2010 and up 4% from $205.3 million in the third quarter of 2011.

The gross margin in the fourth quarter was 44.4%, compared with 45.0% in the fourth quarter of 2010 and equal to the third quarter of 2011.

GAAP net income was $29.1 million or $0.72 per diluted share, compared with $21.3 million or $0.52 per diluted share in the fourth quarter of 2010 and $26.2 million or $0.63 per diluted share in the third quarter of 2011. The fourth quarter of 2011 includes a net tax benefit of $7.8 million, which includes a cumulative benefit of $12.4 million due to the Netherlands Tax Authority's approval of FEI's use of the "Innovation Box" for a portion of its Dutch taxable income. The benefit of the Innovation Box extends into 2012 and later years and lowers the company's estimated overall effective tax rate to approximately 22%. In addition, the company incurred charges to operating expenses of $5.3 million related to certain patent litigation matters, a $2.1 million charge for early termination of a contract, and $1.4 million for impairment of an intangible asset. Adjusting for the tax benefit and the previously mentioned charges and applying an appropriate tax rate results in non-GAAP net income of $25.4 million and non-GAAP diluted earnings per share of $0.63 for the quarter. A reconciliation of these charges and benefits along with their impact on net income and earnings per share is included in a table attached to this press release, along with detailed GAAP statements of operations, balance sheets and additional supplementary information. Management's reasons for presenting non-GAAP information are outlined later in this release.

For the fourth quarter of 2011, gross bookings were $212.0 million. Net bookings were $203.6 million after reduction of the ending backlog due to currency movements. Net bookings were $218.4 million in the fourth quarter of 2010 and $186.4 million in the third quarter of 2011. The backlog at the end of the quarter was $430.7 million.

For the full year 2011, revenue was $826.4 million, an all-time record for the company and up 30% from $634.2 million in 2010. Net income was $103.6 million or $2.51 per diluted share, nearly double the $53.5 million or $1.34 per diluted share posted for 2010. Gross margin for the year increased to 44.5% from 42.5% in 2010.

Total cash, investments and restricted cash at the end of the quarter was $456.1 million, an increase of $20.4 million from the end of the third quarter. Total cash, investments and restricted cash increased $32.3 million during the year, after the repurchase of $50 million of the company's common stock and $14.1 million for the acquisition of TILL Photonics.

"A strong fourth quarter completed a transformational year for FEI," commented Don Kania, president and CEO. "Revenue grew by over 30%, margins improved, we increased R&D spending for future growth, earnings nearly doubled and cash flow from operating activities was over $100 million. We have also taken important steps in the execution of our growth strategy by acquiring companies strategic to our high-growth Life Sciences and Natural Resources businesses, and the announcement of two important collaborations for biology research with NIH and the Knight Cancer Center at Oregon Health Sciences University. Our market position and product lines are strong, and we expect 2012 to be another growth year for FEI."

Guidance for Q1-2012

For the first quarter of 2012, revenue is expected to be in the range of $210 million to $220 million, and bookings are expected to be at least $210 million. GAAP earnings per share are expected to be in the range of $0.60 to $0.65, assuming a 22% effective tax rate.

Non-GAAP Financial Measures

This press release provides financial measures for non-GAAP net income, diluted earnings per share, operating expenses and operating income that exclude certain costs related to the company's estimate of costs associated with potentially settling certain patent litigation, costs related to early termination of a contract, impairment of certain intangible assets and tax benefits associated with an agreement with Dutch tax authorities applicable to a portion of the company's income. Those financial measures are therefore not calculated in accordance with accounting principles generally accepted in the United States ("GAAP"). Management believes that these non-GAAP financial measures provide meaningful supplemental information that enhances management's and investor's ability to evaluate FEI's operating results in comparison to prior periods that did not include similar items.

These non-GAAP financial measures are not intended to be used in isolation and should not be considered a substitute for any other performance measure determined in accordance with GAAP. Investors and potential investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool, including that other companies may calculate similar non-GAAP financial measure differently, limiting their usefulness as a comparative tool. The company compensates for these limitations by providing specific information regarding the GAAP amounts included in or excluded from the non-GAAP financial measures. The company further compensates for the limitations of its use of non-GAAP financial measures by presenting comparable GAAP measures more prominently. Investors and potential investors are encouraged to review the reconciliation of non-GAAP financial measures included with this press release with our GAAP net income and net income per diluted share.

Investor Conference Call -- 2:00 p.m. Pacific time, Wednesday, February 8, 2012

Parties interested in listening to FEI's quarterly conference call may do so by dialing 1-877-941-8609 (U.S., toll-free) or 1-480-629-9818 (international and toll), with the conference title: FEI Fourth Quarter Earnings Call, Conference ID 4501547. A telephone replay of the call will be available at 1-800-406-7325 (U.S., toll-free) or 1-303-590-3030 (international and toll) with the passcode: 4501547#. The call can also be accessed via the web by going to FEI's Investor Relations page at www.fei.com, where the webcast will also be archived.

Safe Harbor Statement

This news release contains forward-looking statements that include statements regarding our guidance for revenue, earnings per share, tax rate and bookings for the first quarter of 2012 and our outlook for 2012. Forward-looking statements may also be identified by words and phrases that refer to future expectations, such as "guidance," "guiding," "expect," "expects," "are expected," "will," "projecting," "estimate," and other similar words and phrases. Factors that could affect these forward-looking statements include, but are not limited to, the global economic environment; lower than expected customer orders and potential weakness of the Materials Science, Electronics and Life Sciences market segments; potential reduced governmental spending due to budget constraints and current uncertainty around global sovereign debt; limitations in our manufacturing capacity for certain products; problems in obtaining necessary product components in sufficient volumes on a timely basis from our supply chain; bankruptcy or insolvency of customers or suppliers; cyclical changes in the data storage and semiconductor industries, which are the major components of Electronics market revenue; fluctuations in foreign exchange, interest and tax rates; changes in tax rate and laws, accounting rules regarding taxes or agreements with tax authorities; the ongoing determination of the effectiveness of foreign exchange hedge transactions; reduced profitability due to failure to achieve or sustain margin improvement in service or product manufacturing; the relative mix of higher-margin and lower-margin products; risks associated with building and shipping a high percentage of the company's quarterly revenue in the last month of the quarter; customer requests to defer planned shipments; increased competition and new product offerings from competitors; lower average sales prices and reduced margins on some product sales due to increased competition; failure of the company's products and technology, including new products, to find acceptance with customers; inability to deploy products as expected or delays in shipping products due to technical problems or barriers; potential shipment or supply chain disruptions due to natural disasters or terrorist attacks; changes to or potential additional restructurings and reorganizations not presently anticipated; reduced sales due to geopolitical risks; changes in trade policies and tariff regulations; changes in the regulatory environment in the nations where we do business; additional selling, general and administrative or research and development expenses; additional costs related to future merger and acquisition activity; and failure of the company to achieve anticipated benefits of acquisitions and collaborations, including failure to achieve financial goals and integrate future acquisitions successfully. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.

About FEI

FEI Company (Nasdaq:FEIC) is a leading supplier of scientific instruments for nanoscale applications across many industries: materials science, life sciences, semiconductors, data storage, natural resources and more. With more than 60 years of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and DualBeams™, which combine an SEM with a focused ion beam (FIB). Headquartered in Hillsboro, Ore., USA, FEI has over 2,000 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.

The FEI Company logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6379

       
       
FEI Company and Subsidiaries
Consolidated Balance Sheets
(In thousands)
(Unaudited)
       
       
  December 31,
2011
October 2,
2011
December 31,
2010
ASSETS      
CURRENT ASSETS:      
Cash and cash equivalents  $ 320,361  $ 288,995  $ 277,617
Short-term investments in marketable securities 16,213 38,720 44,026
Short-term restricted cash 22,564 26,326 22,114
Receivables, net 185,955 200,739 183,254
Inventories, net 182,010 191,646 155,964
Deferred tax assets 18,899 15,175 11,505
Other current assets 27,964 31,435 23,126
Total current assets 773,966 793,036 717,606
Non-current investments in marketable securities 53,341 40,217 38,662
Long-term restricted cash 43,669 41,486 41,377
Non-current inventories 57,575 53,246 47,976
Property plant and equipment, net 85,082 79,524 80,681
Goodwill 58,053 44,802 44,800
Deferred tax assets 934 5,111 1,072
Other assets, net 17,289 14,571 12,248
TOTAL  $ 1,089,909  $ 1,071,993  $ 984,422
LIABILITIES AND SHAREHOLDERS' EQUITY      
CURRENT LIABILITIES:      
Accounts payable  $ 52,470  $ 55,920  $ 51,529
Accrued liabilities 67,386 61,267 51,209
Deferred revenue 72,730 74,983 81,445
Income taxes payable 11,260 26,145 3,715
Accrued restructuring, reorganization and relocation 2,213 470 4,884
Other current liabilities 48,623 38,127 31,306
Total current liabilities 254,682 256,912 224,088
Convertible debt 89,011 89,012 89,012
Other liabilities 49,402 45,544 38,148
SHAREHOLDERS' EQUITY:      
Preferred stock - 500 shares authorized; none issued and outstanding
Common stock - 70,000 shares authorized; 37,866, 37,570 and 38,280 shares issued and outstanding at December 31, 2011, October 2, 2011 and December 31, 2010 493,698 485,746 509,145
Retained earnings 178,661 149,573 75,024
Accumulated other comprehensive income 24,455 45,206 49,005
Total shareholders' equity 696,814 680,525 633,174
TOTAL  $ 1,089,909  $ 1,071,993  $ 984,422
           
           
FEI Company and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
           
  Thirteen Weeks Ended Year Ended
  December 31,
2011
October 2,
2011
December 31,
2010
December 31,
2011
December 31,
2010
NET SALES:          
Products  $ 168,416  $ 161,255  $ 145,548  $ 654,599  $ 479,780
Service and components 44,574 44,080 40,522 171,827 154,442
Total net sales 212,990 205,335 186,070 826,426 634,222
COST OF SALES:          
Products 89,496 85,228 75,087 344,575 262,571
Service and components 28,952 28,882 27,261 114,485 102,387
Total cost of sales 118,448 114,110 102,348 459,060 364,958
Gross margin 94,542 91,225 83,722 367,366 269,264
OPERATING EXPENSES:          
Research and development 21,547 19,212 17,584 78,318 66,274
Selling, general and administrative 47,175 37,051 36,851 158,782 136,465
Restructuring, reorganization and relocation 2,100 47 562 3,215 11,067
Total operating expenses 70,822 56,310 54,997 240,315 213,806
OPERATING INCOME 23,720 34,915 28,725 127,051 55,458
OTHER INCOME (EXPENSE), NET (2,470) (601) (643) (4,186) (3,236)
INCOME BEFORE TAXES 21,250 34,314 28,082 122,865 52,222
INCOME TAX EXPENSE (BENEFIT) (7,838) 8,137 6,738 19,228 (1,326)
NET INCOME  $ 29,088  $ 26,177  $ 21,344  $ 103,637  $ 53,548
BASIC NET INCOME PER SHARE DATA  $ 0.77  $ 0.68  $ 0.56  $ 2.70  $ 1.41
DILUTED NET INCOME PER SHARE DATA 0.72 0.63 0.52 2.51 1.34
WEIGHTED AVERAGE SHARES OUTSTANDING:          
Basic 37,727 38,421 38,209 38,384 38,083
Diluted 41,293 42,030 41,676 42,047 41,737
           
           
FEI Company and Subsidiaries
Consolidated Statements of Operations
(Unaudited)
           
  Thirteen Weeks Ended (1) Year Ended (1)
  December 31,
2011
October 2,
2011
December 31,
2010
December 31,
2011
December 31,
2010
NET SALES:          
Products 79.1% 78.5% 78.2% 79.2% 75.6%
Service and components 20.9 21.5 21.8 20.8 24.4
Total net sales 100.0% 100.0% 100.0% 100.0% 100.0%
COST OF SALES:          
Products 42.0% 41.5% 40.4% 41.7% 41.4%
Service and components 13.6 14.1 14.7 13.9 16.1
Total cost of sales 55.6% 55.6% 55.0% 55.5% 57.5%
GROSS MARGIN:          
Products 46.9% 47.1% 48.4% 47.4% 45.3%
Service and components 35.0 34.5 32.7 33.4 33.7
Gross margin 44.4 44.4 45.0 44.5 42.5
OPERATING EXPENSES:          
Research and development 10.1% 9.4% 9.5% 9.5% 10.4%
Selling, general and administrative 22.1 18.0 19.8 19.2 21.5
Restructuring, reorganization and relocation 1.0 0.3 0.4 1.7
Total operating expenses 33.3% 27.4% 29.6% 29.1% 33.7%
OPERATING INCOME 11.1% 17.0% 15.4% 15.4% 8.7%
OTHER INCOME (EXPENSE), NET (1.2)% (0.3)% (0.3)% (0.5)% (0.5)%
INCOME BEFORE TAXES 10.0% 16.7% 15.1% 14.9% 8.2%
INCOME TAX EXPENSE (BENEFIT) (3.7)% 4.0% 3.6% 2.3% (0.2)%
NET INCOME 13.7% 12.7% 11.5% 12.5% 8.4%
           
(1)  Percentages may not add due to rounding.      
   
   
FEI Company and Subsidiaries
Non-GAAP Income Statement
(In thousands, except per share amounts)
(Unaudited)
   
   
  Thirteen Weeks Ended
December 31, 2011
GAAP Operating Expenses  $ 70,822
Adjustment for:  
Estimate for patent litigation settlement (5,300)
Cost for early termination of a contract (2,100)
Impairment of intangible assets (1,434)
Non-GAAP Operating Expenses  $ 61,988
   
GAAP Operating Income  $ 23,720
Adjustment for:  
Estimate for patent litigation settlement 5,300
Cost for early termination of a contract 2,100
Impairment of intangible assets 1,434
Non-GAAP Operating Income  $ 32,554
   
GAAP Net Income  $ 29,088
Adjustment for:  
Estimate for patent litigation settlement, net of tax 3,765
Cost for early termination of a contract, net of tax 1,492
Impairment of intangible assets, net of tax 1,019
Tax impact of "Dutch innovation box"  (1) (9,955)
Non-GAAP Net Income  $ 25,409
   
GAAP Diluted Earnings Per Share  $ 0.72
Adjustment for:  
Estimate for patent litigation settlement, net of tax 0.09
Cost for early termination of a contract, net of tax 0.04
Impairment of intangible assets, net of tax 0.02
Tax impact of "Dutch innovation box"  (1) (0.24)
Non-GAAP Diluted Earnings Per Share  $ 0.63
   
(1) Adjustment to taxes to reflect impact of "Dutch innovation box" on earnings for periods before Q4 2011.
           
           
FEI Company and Subsidiaries
Supplemental Data Table
(Dollars in millions, except per share amounts)
           
(Unaudited) Q4 Ended
December 31, 2011
Q3 Ended 
October 2, 2011
Q4 Ended
December 31, 2010
Year Ended
December 31, 2011
Year Ended
December 31, 2010
Income Statement Highlights          
Consolidated sales  $ 213.0  $ 205.3  $ 186.1  $ 826.4  $ 634.2
Gross margin 44.4% 44.4% 45.0% 44.5% 42.5%
Stock compensation expense  $ 3.3  $ 2.2  $ 2.5  $ 11.1  $ 10.5
Net income  $ 29.1  $ 26.2  $ 21.3  $ 103.6  $ 53.5
Diluted net income per share  $ 0.72  $ 0.63  $ 0.52  $ 2.51  $ 1.34
Interest income add back included in the calculation of diluted EPS  $ 0.5  $ 0.5  $ 0.5  $ 1.8  $ 2.3
Sales Highlights          
Sales by Market Segment          
Electronics  $ 54.8  $ 56.6  $ 80.7  $ 259.7  $ 222.8
Materials Science 91.8 74.4 47.3 292.1 182.4
Life Sciences 21.8 30.2 17.6 102.8 74.6
Service and Components 44.6 44.1 40.5 171.8 154.4
Sales by Geography          
USA & Canada  $ 59.0  $ 60.4  $ 68.0  $ 257.2  $ 204.0
Europe 69.5 74.5 62.0 261.3 207.4
Asia-Pacific and Rest of World 84.5 70.4 56.1 307.9 222.8
Gross Margin by Market Segment          
Electronics 53.7% 54.3% 53.7% 52.8% 50.2%
Materials Science 43.5 40.9 42.3 43.1 41.0
Life Sciences 44.0 49.1 40.7 45.8 41.0
Service and Components 35.0 34.5 32.7 33.4 33.7
Bookings and Backlog          
Bookings - Total  $ 203.6  $ 186.4  $ 218.4  $ 785.3  $ 751.5
Book-to-bill Ratio 0.96 0.91 1.17 0.95 1.18
Backlog - Total  $ 430.7  $ 440.1  $ 471.9  $ 430.7  $ 471.9
Backlog - Service and Components 87.4 91.9 81.3 87.4 81.3
Bookings by Market Segment          
Electronics  $ 72.5  $ 40.3  $ 76.2  $ 253.4  $ 263.8
Materials Science 71.5 75.8 77.6 266.9 232.8
Life Sciences 19.5 25.7 23.5 87.0 87.1
Service and Components 40.1 44.6 41.1 178.0 167.8
Bookings by Geography          
USA & Canada  $ 48.6  $ 73.0  $ 80.9  $ 216.8  $ 258.6
Europe 51.6 46.5 59.5 239.6 220.9
Asia-Pacific and Rest of World 103.4 66.9 78.0 328.9 272.0
Balance Sheet Highlights          
Cash, equivalents, investments, restricted cash  $ 456.1  $ 435.7  $ 423.8  $ 456.1  $ 423.8
Operating cash generated (used)  $ 48.6  $ 33.9  $ 52.5  $ 101.4  $ 75.0
Accounts receivable  $ 186.0  $ 200.7  $ 183.3  $ 186.0  $ 183.3
Days sales outstanding (DSO) 80 89 90 80 90
Inventory turnover 2.5 2.3 2.6 2.5 2.6
Fixed asset investment  $ 4.7  $ 3.3  $ 3.6  $ 13.8  $ 8.9
Depreciation expense  $ 4.9  $ 4.8  $ 4.5  $ 18.9  $ 17.4
Working capital  $ 519.3  $ 536.1  $ 493.5  $ 519.3  $ 493.5
Headcount (permanent and temporary) 2,074 2,016 1,813 2,074 1,813
Euro average rate 1.351 1.416 1.36 1.393 1.327
Euro ending rate 1.294 1.343 1.339 1.294 1.339


            

Contact Data

GlobeNewswire